Total Funding
31
5
Total FundingVenture - Series Unknown raised
Growth Score
-3 pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
352606
Geneius is a Biotechnology company.
- Alfred Slanetz: President & CEO
About the Company
Geneius Biotechnology is a T cell immunotherapy company focused on therapies for cancer. There is growing evidence for the potential of T cell immunotherapy for successful treatment of cancer patients. We 'educate' a patient's T cells to target ONLY the multiple mutations in the patient's cancer. That enables a broad attack on
the cancer with no "off-target" toxicity. Through a transformative academic collaboration we will move products from bench to bedside. We are currently developing products for both hematologic and solid cancers through our academic collaboration. Pending financing, we expect to start clinical trials by the end of next year.
